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Abstract
According to the World Health Organization (WHO), worldwide, 15 million people suffer stroke 
each year. Stroke, i.e. the sudden and severe reduction of blood flow to a brain region, is the second 
leading cause of death and the third leading cause of disability. Stroke is also a leading cause of 
dementia and depression. A focal brain damage inevitably causes a drastic alteration of the whole 
complex neural network that characterizes the affected area. Although stroke damage can be 
devastating, many patients survive the initial event and display a spontaneous recovery, which can be 
further increased by rehabilitation therapy. Recovery is possible due to a reorganization of spared areas 
and connections, i.e. neuroplasticity.
Functional recovery is highly variable in stroke patients and strongly depends on many factors (lesion
location and volume, etc.). Currently, there are no ways of predicting either the degree or time course
of recovery in individual subjects. For these reasons, the identification of biomarkers is crucial in the
design  and  interpretation  of  stroke  rehabilitation  trials.  Therefore,  the  aim  of  this  work  is  the
development of new prognostic and therapeutic tools in preclinical models.
In this study I exploit a mouse model of stroke, the Middle cerebral artery occlusion (MCAO),
that shows a higher variability and is thus closer to the human condition. I conducted experiments to
evaluate the occurrence of motor deficits using a battery of behavioral tasks: gridwalk test, skilled
reaching test, and retraction task in the  M-platform (a robotic device that permits to quantitatively
evaluate several kinetic/kinematic  parameters  related to forelimb  movement). Moreover,  the
ischaemic  lesion  and  electrophysiological  alterations  was  analysed  by  means  of  histology  and
electroencephalographic signals (EEG) respectively. I studied how these mechanisms are altered by
stroke, combining the data all these parameters, in order to define possible biomarkers that predict
long-term motor recovery.
The  results  obtained,  permit  new  opportunities  for  therapeutic  approaches  after  stroke
allowing the definition of more effective rehabilitation paradigms that can be translated into clinical
practice. 
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Sumário
Segundo a Organização Mundial da Saúde (OMS), no mundo todo, 15 milhões de pessoas
sofrem de Acidente Vascular Cerebral (AVC) a cada ano. AVC, nomeadamente, a redução súbita e
severa do fluxo sanguíneo para uma região cerebral,  é a segunda principal causa de morte e a
terceira principal causa de incapacidade. O AVC também é uma das principais causas de demência e
depressão.  Um  dano  cerebral  focal  inevitavelmente  causa  uma  alteração  drástica  de  toda  a
complexa rede neural que caracteriza a área afetada. Embora o dano por AVC possa ser devastador,
muitos pacientes sobrevivem ao evento inicial e apresentam uma recuperação espontânea, que pode
ser aumentada pela terapia de reabilitação. A recuperação é possível devido a uma reorganização de
áreas e  conexões poupadas,  ou seja,  a  neuroplasticidade.  A recuperação funcional  é  altamente
variável em pacientes com AVC e depende fortemente de muitos fatores (localização e volume da
lesão, etc.). Atualmente, não há maneiras de prever o grau ou o decurso da recuperação individual.
Por essas razões, a identificação de biomarcadores é crucial no desenho e interpretação de estudos
de  reabilitação  de  AVCs.  Portanto,  o  objetivo  deste  trabalho  é  o  desenvolvimento  de  novas
ferramentas prognósticas e terapêuticas em modelos pré-clínicos.
Neste estudo exploro um modelo em murganho de AVC, a oclusão da artéria cerebral média
(MCAO), que mostra uma maior variabilidade e, portanto, está mais próximo da condição humana. 
Conduzi experimentos para avaliar a ocorrência de déficits motores utilizando uma bateria de tarefas
comportamentais: gridwalk test, teste de alcance qualificado e tarefa de retração na plataforma M
(um  dispositivo  robótico  que  permite  avaliar  quantitativamente  vários  parâmetros
cinéticos/quinemáticos relacionados ao movimento dos membros anteriores).
Para além disso, a lesão isquêmica e as alterações eletrofisiológicas foram analisadas por meio de
histologia e sinais eletroencefalográficos (EEG), respectivamente. Estudei como esses mecanismos
são alterados pelo AVC, combinando os dados obtidos, a fim de definir possíveis biomarcadores que
prevêem a recuperação motoria a longo prazo.
Os resultados obtidos, consentem novas oportunidades de abordagens terapêuticas após
AVC, permitindo a definição de paradigmas de reabilitação mais eficazes, que podem ser traduzidos
na prática clínica.
Palavras-chave:  Acidente  Vascular  Cerebral  (AVC),  Artéria  Cerebral  Média,  Biomarcadores,
Recuperação, Função motoria
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Chapter 1. Introduction
1.1 Stroke Description 
1.1.1 Historical references
The first use of the term "stroke" was in 1599, attributing the sudden appearance of symptoms
to a ‘stroke of God’s hand’ (Pound et al., 1997). It was not adopted into the medical lexicon of the time
and  the  doctors  used  the  term  “apoplexy”,  a  diagnosis  that  had  been  in  existence  since  the
Hippocratic writings (Karenberg and Moog, 1997).
Apoplexy was a generic term, which describes a condition in which the patient had a sudden abolition
of all the activities of the mind with the preservation of the pulse and breathing. Hippocrates described
a patient who experiences sudden pain, loses his speech, with a gasp in the throat, urine without
awareness and does not respond (Pound et al., 1997).
In the Hippocratic writings, the word used to describe such results was "paraplessia" and, although
now obsolete, is meant as a synonym for what we now define "paraplegia" (Coupland et al., 2017).
It was only in the seventeenth century and the rise of the anatomical doctors that this position was
challenged. Among the most important advances in stroke comprehension were those made by the
physician Johan Jakob Wepfer. Wepfer is credited with being the first to observe that apoplexy was
caused by an intracranial haemorrhage (Pound et al., 1997).
Over time, the number of autopsies performed has increased and the most significant work published
in the 17th century was the Sepulchretum sive of Anophetic Practica by Theophile Bonet. 
Bonet's  Sepulchretum was much appreciated, but was eventually replaced by the publication of  De
Sedibus et  Causis Morborum per Anatomen Indagatis by Giovoanni Morgagni in 1761. Morgagni,
considered to be the founder of pathology, built on Bonet’s work but with fundamental differences: he
did not recognize cranial trauma as a cause of apoplexy (although he admitted that he could cause a
"apoptotic condition") and divided the causes of apoplexy into two main groups: "sanguineous" and
"serous" (Schutta, 2009). 
With such observations, apoplexy began to be understood as a predominantly vascular disease, a
position strengthened by the discoveries of John Abercrombie (early 19th century) and Rudolf Virchow
(early  20th  century).  The first  recognized  a  link  between arterial  occlusive  disease  and  areas  of
cerebral softening (caused by infarcts) and the latter reclassified the causes of apoplexy as sanguinea
(hemorrhagic) and ischemia (Virchow term) (Coupland, 2017). So the term “cerebrovascular disease”
emerged and apoplexy faded from use (Figure. 1.1). 
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1.1.2 Definition and Symptoms
In 1970, the World Health Organization (WHO) defined stroke as “rapidly developed clinical
signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to
death, with no apparent cause other than of vascular origin” (Aho et al., 1980). Although still widely
used, the definition of the World Health Organization is strongly based on clinical symptoms and is
now considered obsolete by the American Heart Association and the American Stroke Association due
to significant advances in nature, timing, and stroke recognition. Today the most current definition
provided by WHO is: “A stroke is caused by the interruption of the blood supply to the brain, usually
because a blood vessel bursts or is blocked by a clot. This cuts off the supply of oxygen and nutrients,
causing damage to the brain tissue.” 
Typical  stroke  symptoms  include  sudden  unilateral  weakness,  numbness  or  visual  loss,
impaired speech, ataxia and vertigo. Associated symptoms (e.g. headaches) vary and usually reflect
the cause or consequences of stroke. Atypical symptoms include isolated vertigo, binocular blindness,
amnesia, stridor, alien hand syndrome, confusion, and altered consciousness (Coupland et al., 2017).
1.1.3 Hemorrhagic/ischemic stroke
Pathological subtypes of stroke include: ischemic stroke (cerebral infarction) and hemorrhagic
stroke (intra-cerebral hemorrhage and subarachnoid hemorrhage). The proportions of pathological and
aetiological subtypes of stroke varies among populations, in relation to age, nationality and nation
lifestyle. Ischemia is characterized by  an insufficient blood supply (Figure. 1.2 A), while hemorrhage
is characterized by an excess of blood inside the skull (Figure. 1.2 B).
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Figure1. 1: Figure depicts an historical timeline (Coupland et al., 2017).
Hemorrhagic  stroke  refers  to  bleeding  inside  the  skull  either  in  the  brain  or  at  the  level  of  the
meninges.  Bleeding in  the  brain  parenchyma or  vascular  system produces an impairment  in  the
intracerebral connections and in the pathway of gray and white matters. This bleeding is due to the
rupture of small blood vessels, arterioles and capillaries in the cerebral parenchyma, and therefore,
blood oozes into the brain and forms a localized blood collection called hematoma. When hematoma
is formed, it exerts pressure on the regions of the brain and can injure these surrounding tissues.
Edema often develops around the hematoma, further adding to the extra volume of abnormal tissue.
Large hemorrhages are usually fatal because they increase pressure within the skull, squeezing vital
regions in the brainstem. 
Bleeding into the fluid around the brain is referred to as subarachnoid hemorrhage, in which the blood
collects under the arachnoid membrane that lies over the pia mater. In contrast to the situation in intra-
cerebral hemorrhages, where a localized hematoma causes loss of function related to a specific area
(Figure. 1.3), in patients with subarachnoid hemorrhages there are more systemic symptoms (e.g.
headache, vomiting, seizures, decreased consciousness, etc.) (Van Gijn et al., 2007).
The second main types of stroke are ischemic (Amarenco et al., 2009). The term refers to the
insufficiency of blood supply to an organ. 
There are three main categories of cerebral  ischemia, called:  thrombosis,  embolism and systemic
hypo-perfusion (Figure. 1.4). Each one indicates a different mechanism of lesion of blood vessels or a
reason of decreased blood flow. 
3
Figure1. 2: Subtypes of stroke. (A) Ischemic stroke; (B) Hemorrhagic stroke. (Gillbert et al., 2014)
Figure1. 3: Types of hemorrhagic stroke (Caplan and Simon, 2015).
Thrombosis refers to a local problem within a blood vessel that supplies a portion of the brain. The
process is often a disease of the blood vessel, which narrows blood flow through that vessel. Often, a
thrombus is superimposed on the localized vascular process. Embolism refers to a breaking loose of
materials (often thrombi, but occasionally bacteria, cholesterol crystals, fat, foreign bodies, etc.) from a
proximal source to block a distant vessel farther along the circulatory path. The downstream blocked
vessel causes infarction to a localized brain region in the same way that a primary vascular lesion (i.e.
thrombosis) does. Systemic hypoperfusion is characterized by a global decrease in blood flow to the
head rather than a localized decrease as occurs in thrombosis and embolism.  Abnormal heart per-
formance could lead to low pressure in the cardiovascular system.
Abnormally slow or fast heart rhythms, cardiac arrest and heart failure can reduce blood flow to the
head and brain. Another cause of decreased circulatory function is a lowering of blood pressure and
blood flow due to an inadequate amount of blood and fluid in the vascular compartment of the body.
Bleeding, dehydration and fluid loss in body tissues (shock) can lead to inadequate brain failure.
4
Figure1. 4: Type of ischemic stroke. (A) Thrombosis; (B) Embolism; 
(C) Systemic Hypoperfusion. (Caplan and Simon, 2015).
1.1.4 Incidence
Stroke is the second leading cause of death and the third leading cause of disability (WHO).
Worldwide, 15 million people suffer stroke each year, of these, 5 million die and another 5 million are
permanently disabled. Current trends suggest that the number of annual deaths will rise to 6.7 million
(World Stroke Organization (WSO)). 
Globally, men continue to have a higher incidence of ischemic stroke than women, while no
significant gender differences were observed in the incidence of hemorrhagic stroke (Barker-Collo et
al., 2015). It is possible that the differences between men and women are partialy explained by the fact
that in some countries women are more sensitive to health information, have a more healthy behaviour
and have better access to primary prevention. An alternative explanation is that the neurovascular risk
factors are more frequent and severe in men and have decreased more rapidly in women (e.g. the
differential rate of smoking, with men having a higher prevalence of smoking than women). The total
health loss due to stroke as measured by Disability-adjusted life years (DALYs) is similar for men and
women for both stroke subtypes. 
The  increasing incidence and mortality  rates of  ischaemic stroke in the last  decades represent  a
significant improvement in the health of the population and is observed for both sexes and in all groups
of age. These significant improvements are concomitant with  interventions for a better prevention of
cardiovascular risks.
According to the statistics of SAFE, in Portugal the incidence is 15.208 strokes per year, i.e.,
each year, in 1000 people, approximately 2 suffer a stroke and 41% of stroke survivors are unable.
From 2015 to 2035 the estimated increase in incidence is 31%, with a fatal increase of 40% and DALY
loss of 29% (The Burden of Stroke in Europe, 2017).
1.1.5 Risk factors
Hypertension, hypercholesterolaemia, carotid stenosis and atrial fibrillation are known to be
risk factors for stroke because clinical  studies have shown that  treating these conditions reduces
stroke (Xie et al., 2016). Cigarette smoking, excessive alcohol use, insulin resistance and diabetes
mellitus are also likely to be risk factors. O ther comorbidity factors are represented by environmental
air  pollution,  health condition,  high risk  diet  and poor nutrition,  physical  inactivity,  obesity,  ageing,
variability  of  blood  pressure,  disordered  breathing  of  sleep,  chronic  inflammation,  chronic  kidney
disease, headache, depression, stress, long hours of work.  These factors, if modified, could reduce
stroke incidence.
1.1.6 Effects in Nervous System 
 Global ischemia produces the non-focal cessation of blood flow to the entire brain, as happens
in  cardiac  arrest.  Energy  deficiency  from  impaired  oxidative  metabolism  occurs  rapidly  when
substrates for adenosine triphosphate (ATP), oxygen and glucose decrease. Neuronal injury and cell
death begin within 4 minutes. The distinctive morphological sign of the neuronal lesion is the change of
ischaemic  cells  characterized  by  microvacuolization  in  the  cytoplasm  (Song  and  Yu,  2014).  At
ultrastructural level, the vacuoles mainly represent dilated mitochondria with Ca2+ loading (Figure.
1.5).
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Focal ischemia produces an altered blood flow in a portion of the brain as occurs in thrombotic and
embolic  strokes.  Here,  there  is  a  decrease  of energy,  more  in  the  ischaemic  core  than  in  the
surrounding cerebral tissue, referred to as “penumbra” (Arumugam et al., 2018). Na + / K + -ATPase,
responsible  for  maintaining the intracellular  concentration of  K+,  fails,  resulting in  loss of  K+ and
consequent excessive depolarization of  downstream neurons. This produces a cortical  depression,
producing further neuronal and astrocytic depolarization  and infarct extension. Cellular depolarization
causes  intracellular  Ca2+  entry  through  activation  of  voltage-gated  Ca2+  channels  and  voltage-
sensitive glutamate receptor-gated channels. Anaerobic metabolism causes lactate accumulation and
acidosis in regions of the ischaemic brain. The presence of acidosis activates Ca2+-permeable, acid-
sensing ion channels,  further  exacerbating calcium dysregulation.  Intracellular  Ca2+ buffering and
sequestration mechanisms in mitochondria and endoplasmic reticulum become overwhelmed catabolic
processes are activated, mitochondrial function fails, and cell death pathways are mobilized.
Cell death occurs more rapidly in the infarct core and more slowly (after several hours or days)
in the penumbra (Caplan and Simon, 2015). Rapid cell death occurs through the process of necrosis,
with swelling of cells and organelles, breakage of the membrane and leakage of cellular content into
the  extracellular  space  with  consequent  inflammation.  The  swelling  of  the  organelles  results  in
cytoplasmic microvacuolysis. In the penumbra, cell death occurs in a slower, more energy-dependent
and more regulated way, characterized by programmed cell death. Here, in contrast to necrosis, the
affected cells are  characterized by shrinkage, membrane blebbing without breakage, aggregation of
the chromatin on the nuclear membrane, preservation of the integrity of intracellular organelles with
subsequent dispersion of the cellular content in apoptotic bodies bound to the membrane and finally
fragmentation of the DNA. In this case, inflammation does not result. 
Several pathways contribute and facilitate cell death. Excitotoxicity refers to the pathological
effect of excitatory neurotransmitters, in particular glutamate, which is present in high concentrations in
the  extracellular  space  of  the  ischaemic  brain.  The  increased  glutamate  concentration  produce
depolarization-induced synaptic  release,  reversal  of  astrocytic  glutamate uptake,  and  activation  of
voltage-sensitive glutamate receptor-gated channels. Extracellular glutamate binds to the postsynaptic
6
Figure1. 5: Structure of microvacuolated hippocampal neuron. Vacuoles, 
black arrows, are dilated mitochondria which show calcium deposits, white 
arrows (Caplan and Simon, 2015).
N-methyl-D-aspartate (NMDA) receptor, in particular the extrasynaptic receptors containing an NR2B
subunit.  The  NMDA  receptor  gates  a  Ca2+-permeable  ion  channel  and  its  activation  produces a
further  influx of  Ca2+.  Moreover,  the entry  of  Ca2+ from this  path  leads  to  the activation  of  the
neuronal  nitric  oxide synthase,  resulting in  the  production  of  reactive  oxygen species (ROS) that
produce mitochondrial and DNA damage, ion channel activation, protein modification and activation of
cell death paths.
The Ca2+  released  increases free radicals, triggers the expression of a number of proinflammatory
genes by inducing the synthesis of transcription factors (e.g. interferon regulatory factor 1). Therefore,
inflammation  mediators,  such  as  tumor  necrosis  factor  α  (TNFα )  and  interleukin  1β (IL-1β),  are
produced by injured brain cells. As a consequence, the expression of adhesion molecules is induced
on the surface of endothelial cells,  where they interact with the complementary surface receptors on
neutrophils. Neutrophils, in turn, adhere to the endothelium, cross the vascular wall and enter the brain
parenchyma. Macrophages and monocytes follow neutrophils, migrating into the ischaemic brain and,
five or seven days after ischaemia, becoming the predominant cells. Chemokines (e.g. interleukin 8)
are produced in the injured brain and drive the migration of the inflammatory cells within the blood to
their target together with resident brain cells that are also involved in the inflammatory response. From
four to six hours after ischaemia, astrocytes become hypertrophic, while microglial cells assume a
tipical  amoeboid  morphology  of  activated  microglia.  Twenty-four  hours  after  the  occlusion,  the
microglial reaction is  predominant  in the ischaemic brain, leading to an increasing inflammation that
contributes to brain damage, and finally, to the impairment of sensory and motor function (Figure. 1.6).
1.2 Animal Model
1.2.1  Focal cerebral ischemia model
Several  animal  models  have been developed in  the  recent  years to  study molecular  and
cellular mechanisms following a focal ischaemic insult in the brain and to evaluate possible therapeutic
approaches  for  the  restoration  of  function.  In  particular,  rodent  models  allow  a  coordinated
electrophysiological, behavioural, biochemical, and anatomical analysis of post stroke modifications. At
the same time, small animals are  relatively low expensive, they are easy to obtain and  they can be
maintained for longer periods of time. These reasons, make rodents a reasonably good model for
understanding the changes in the intra-cortical communications following a brain injury. 
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Of course, animal models that reproduce human stroke have several limitations, some of which are
difficult to overcome. The human clinical stroke is often a result of a number of predisposing factors
such  as  depression,  diabetes,  obesity  and  circulatory  problems.  In  the  animal  models,  stroke  is
induced in young and healthy individuals and in strictly controlled experimental conditions, that cannot
reproduce the complexity and heterogeneity of a human stroke. 
Moreover, there are differences between mammalian species and the anatomy of the tract. Primates
present a higher number of corticospinal neurons than the rodents and a large number of corticospinal
fibres represent a major volume of white matter in the internal capsule of primates compared with
rodents.   
The corticospinal tract (CST) is the main descending pathway from the cerebral cortex to spinal cord
motorneurons and its cortical territories and/or fibre tracts are usually injured in stroke. Despite some
differences in the CST anatomy among mammalians species, in all of them, the CST originates from
layer V pyramidal neurons in the cerebral cortex. Most of corticospinal neurons are localized in a large
region of frontoparietal cortex corresponding to primary motor cortex (M1) and primary somatosensory
cortex (S1). Moreover, in all mammalians, the corticospinal fibres descend across the internal capsule
and medullary pyramids, suggesting that, this pathways emerged early in mammalian evolution (Nudo,
2007).  To the contrary, there are some difference in the proportion of crossing CST fibers. In fact, in
primate  fibres that  cross  to  the  contralateral  side  of  the  spinal  cord  prevail,  while  in  rodents the
ipsilateral  component  is  greater  and  represents  a  potential  compensatory  pathway.  Also  for  this
reason, rodents often show a better and faster recovery after injury with respect to  humans. 
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Figure1. 6: Signalling pathways involved in the cerebral ischemic cascade (Yang et al., 2018).
In all mammalian species, including all rodents and primates, the motor and somatosensory cortices
shows a topographic arrangement, with at least 2 somatosensory representations (S1 and S2), that
have been identified in the parietal cortex. However, in primates, S1 can be subdivided into additional
areas, including areas 3a, 3b, 1, and 2. In rodents,  a primary and a putative premotor cortex have
been  identified,  in  particular  regarding  the  forelimb  motor  representation,  using  intracortical
microstimulation experiments, a caudal  and rostral forelimb area (CFA and RFA respectivey) have
been described  (Tennant,  2010).  In  primates,  frontal  cortex has been subdivided  into  >5  regions
including M1,  supplementary motor  area (SMA),   ventral  premotor  cortex (PMv),  dorsal  premotor
cortex (PMd),  and cingulate  motor  areas.   Each of  these areas has been further  subdivided into
subfields (such as SMA proper and pre-SMA) (Figure. 1.7)
1.2.2 Middle cerebral artery occlusion (MCAO) 
In humans, ischemic strokes occur  more often in the brain region provided by the middle
cerebral arteries (MCAs). The MCAs are relatively large cerebral arteries arising from the circle of
Willis  (Figure. 1.8), and the occlusion of one of these arteries produces a large area of ischaemic
damage and neuronal death (Dorrance and Fink, 2015). The MCA is one of the major arteries that
provides blood supply to the brain. In humans, it arises from the bifurcation of the ICA (internal carotid
artery) as the larger and more direct branch. It is divided into three segments: M1 is the horizontal
segment, M2 is the insular segment, M3 is the opercular segment  (Figure. 1.9). The right and left
MCAs are connected to the anterior cerebral arteries and the posterior communicating arteries, which
connect to the posterior cerebral arteries, creating the Circle of Willis. 
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Figure1. 7: Comparison of somatosensory and motor areas in primates
and rodents (Nudo, 2007).
The  middle  cerebral  artery  occlusion  (MCAO)  model  is  widely  used  for  inducing  a  focal
cerebral ischemic stroke in rodents. To study the lesion, MCAO can be performed via transient or
permanent model. Regarding transient model, MCAO is achieved through insertion of an intraluminal
suture into  the  external  carotid  or  common carotid  artery  and thus result  in  partial  restoration of
perfusion after transient MCAO. While, in the second model, blood flow is permanently occluded. This
model will be described in the next section.  
1.2.3 Permanent Electrocoagulation Model of MCAO
The electrocoagulation model of MCAO in rodents was developed by Tamura and colleagues
(Tamura et al.,1981). In this model a craniotomy is accomplished in order to expose the MCA on the
brain  surface.  Electrocoagulation forceps are used to  coagulate  a portion of  MCA to permanently
occlude the vessel. 
After occlusion, the core has less than 20% of baseline blood flow and fails to regain its initial condition
while,  in the penumbra, blood flow re-increases towards the midline, as tissues in this region are
supplied by other artery systems that were not blocked during the stroke (Li and Murphy, 2008) It has
been showed that the dendritic arborisation follows the gradient of blood supply: in particular, going
away from the core of the lesion, towards the healthy tissue, neurons are characterized by a more
complex fine dendritic structure app (Figure. 1.10).
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Figure1. 8: Circle of Willis (Wang et al., 2016).
Figure1. 9: Middle cerebral artery (MCA) (Cerekja et 
al., 2011).
Figure1. 10: Cross section through the rodent cortex that shows the stroke core (darker brown) and 
penumbra (lighter brown) (Murphy and Corbett, 2009).
The advantage of this model is that the section of  occluded MCA, can be varied (distal or proximal
occlusion) and this can induces a stroke in cortical territory or both cortical and subcortical territories.
A distal occlusion of MCA will induce a cortical lesion, while a proximal occlusion, at the origin of MCA,
will induce a great subcortical and cortical infarct. 
The limitation of this model is that it induces permanently MCAO and therefore the riperfusion is not
possible and due to the position of craniotomy, injury to the temporalis muscle may occur. (Tamura et 
al., 1981).  
1.3 Post-stroke Rearrangements 
1.3.1 Spontaneous recovery
A focal  brain  damage  inevitably  causes  a  drastic  alteration  of  the  whole  complex  neural
network  that  characterizes  the  affected  area.  Although stroke  damage can  be  devastating,  many
patients  survive  to  the  initial  event  and  present  a  spontaneous  recovery,  which  can  be  further
increased by rehabilitation therapy. The destruction of neural networks, in fact, usually stimulates a
rewiring and a reorganization of the connections and this plastic environment is highly sensitive to the
experience following the damage (Stroemer et al., 1993; Li and Carmichael, 2006). Particularly, such
phenomena involve the perilesional tissue and the surrounding brain areas of the injured hemisphere.
Nevertheless, plastic phenomena can occur also in some portions of the contralateral hemisphere, as
well as in subcortical and spinal regions. This window of plasticity, a sort of post-stroke critical period,
appears to be time-limited and has a peak in the acute – early subacute phase. In this time window,
behavioural training has its maximum effect (Biernaskie et al. 2004).  
Recovery is defined by clinical and biomedical scientists as the improving of the sensory and motor
performance that occurs after the stroke (Murphy and Corbett, 2009), although the re-emerging post-
stroke behaviour is probably not identical to pre-stroke behavioural patterns due to the loss of neurons
that have highly specific functions. As a matter of fact, in humans complete recovery of function in
distal musculature is rare (Nudo et al., 1996). Thus, the performance improvement is partially due to
compensation, which allows a partial return to pre-stroke motor performance levels. 
As mentioned before, the motor and sensory cortices are organized in somatotopic functional maps
showing high levels of use-dependent plasticity (Nudo et al., 1996). Motor maps reflect the coupling of
specific neurons of the motor cortex to the muscles, while sensory maps represent the association of
body  parts  to  the  neurons  of  the  sensory  cortex.  Motor  maps  allow  both  the  learning  and  the
expression of movements and therefore represent a type of 'motor engram' or memory trace (Monfils
et al., 2005). As a result, when the regions of the cortex are destroyed by a stroke, the motor engram
is lost. As such, the only way to get a real recovery could be to replace the destroyed circuits, thus, the
term recovery usually refers to various degrees of behavioural compensation that are provided by the
remaining and newly developed brain circuits and that lead to altered behavioural  patterns and/or
tonovel strategies to improve performance.
11
1.3.2 Proportional recovery rule
The plasticity appears time-limited and has a peak in acute phase. In this time, the recovery is
can be improved by rehabilitation therapy. This period of plasticity is related to spontaneous recovery
which is observed in stroke patients. Recovery is variable and difficult to predict, i.e., only 38% of
patients who showed an initially paralysed upper limb regained some dexterity by 6 months (Kwakkel
et al. 2003), and in general two-thirds of patients perceived that loss of arm function was still a major
problem after 4 years (Broeks et al. 1999).
Several factors are associated with poor outcomes, however the dominant one for predicting long term
upper limb functionality is the initial severity of motor deficit (Coupar et al. 2012). The ability of initial
deficit  to  predict  upper  limb  recovery  was  first  quantified  such  as  “proportional  recovery”  rule
(Prabhakaran et al. 2008). In line with theory, by 3 month, patients shall regain ~70% of its motor
impairment showed on day 3 after stroke. In other words, the more severe is the deficit, the more the
patient will recover, with a constant factor of 70%. However, initial deficit predicts outcomes only in
patients with mild and moderate deficit. However, among patients who present high severity, recovery
is proportional to the initial deficit in approximately half cases, in the other half case no substantial
recovery is not seen  (Figure. 1.11). Indeed, it could be really interesting to understand if predictive
factors exist,  that could helping in distinguish in the early phase which patients will  spontaneously
recover later and which not.  
1.3.3.  Clinical outcomes
If an ischemic insult occurs in the motor cortex, one or more body parts contralateral to the
infarct result impaired or paretic:~80% of stroke survivors experience impairment of movement on one
side of the body (Langhorne et al, 2009). The degree of motor impairment depends on many factors,
such as the extent of the infarct, the identity of the damaged region and the effectiveness of the initial
neuroprotective interventions. In the first weeks after stroke, limited spontaneous recovery can occur.
About 26% of stroke survivors are able to carry on everyday activities (Activity of Daily Living or ADLs,
i.e. eating, drinking, walking, dressing, bathing, cooking, writing) without any help, but another 26% is
forced to shelter in a nursing home (Carmichael, 2005). Impairments of upper and lower limbs are
particularly disabling as they make very hard to have a sufficient degree of independence in ADLs.
Several scoring systems are exploited in the clinic to objectively quantify the impairment caused by a
stroke. In human, the clinical quantification of impairments caused by a stroke is measured by two
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Figure1. 11:  Different recovery curves of patients with initially severe upper limb 
impairment. Recovery as predicted (blue) or poor recovery (red) (Ward 2017).
main  scoring  systems.  One  of  them  is  the  National  Institutes  of  Health  Stroke  Scale  (NIHSS),
composed of 11 items, each scoring a specific ability between a 0 and 4. For each item, a score of 0
typically indicates normal function in that specific ability, while a higher score is indicative of some level
of impairment. The individual scores from each item are summed in order to calculate a patient's total
NIHSS score. The maximum possible score is 42, with the minimum score being a 0. The NIHSS
focuses on different  aspects: level  of  consciousness,  horizonal eye movements,  visual field, facial
palsy,  movement  of  fore-  and  hindlimb,  limb  ataxia,  somatosensation,  language,  speech  and
inattention.  Another scale that is widely utilized in the field is the Fugl-Meyer Assessment, which is
more specific for sensorymotor function. Each item of the scale is scored from 0 to 2: a zero score is
given for the item if the subject cannot do the task and a score of 2 is given when the task is performed
fully. However, reflex activity is measured using 2 points only, with a score of 0 or 1 for absence and
presence of  reflex respectively.  Fugl-Meyer  scale  assesses five  domains:  motor  function,  sensory
function,  balance,  range of  motion of  joints and joint  pain.  The maximum total  score that  can be
obtained  in  Fugl-Meyer  assessment  is  226,  though  it  is  common  practice  to  assess  all  domains
separately. 
1.4 Biomarkers of Stroke Recovery
1.4.1. Measures of motor function
Stroke remains a major  cause of  adult  disability,  and the recovery of  motor  function after
stroke is crucial for the patient to regain independence. However, making accurate predictions of a
patient's  motor  recovery  and  results  is  difficult  if  it  is  based  only  on  clinical  evaluation.  Clinical
assessment of motor impairment within a few days of stroke may help predict subsequent recovery,
while  neurophysiological  biomarkers  of  corticomotor  structure  and  function  may help  predict  both
motor recovery and motor outcome after stroke (Stinear, 2017).  A biomarker of stroke recovery can be
defined as an indicator of disease state that could be used to understand outcome or predict recovery
or  treatment  response.  In  this  context,  it  is  useful  to  clarify  the  use  of  the  terms “outcome” and
“recovery”.  “Outcome”  refers  to  a  measure  at  a  single  time-point,  and  is  therefore  insensitive  to
whether the patient’s motor performance has improved, remained stable, or deteriorated over time
after stroke. In contrast, the “recovery” is evaluated over time and can be calculated as the absolute
difference between baseline and subsequent clinical scores, or better as percentage of the available
improvement in a specific scoring system.
The combination of  biomarkers can provide clinically  useful  information when planning a patient's
personalized rehabilitation. These biomarkers can also be used for patient selection and stratification
in  studies  studying  early  post-stroke  rehabilitation  interventions.  Ongoing  multi-centre  studies
incorporating motor biomarkers could help bring their use into routine clinical practice. 
A biomarker may also provide a measure of the underlying molecular/cellular processes, which may be
difficult  to  assess directly  in  patients  (Bernhardt  et  al.  2016).  This  would  be particularly  useful  in
identifying when and which neural  mechanisms to target,  and in  some cases at  what  dose,  with
interventions  to  promote  stroke  recovery  (Cramer  et  al.  2007).   Methods  for  accurate  long-term
outcome/recovery prediction would allow clinical studies to be stratified on the basis of neurobiological
recovery potential in a way that is currently not possible when studies are conducted in the absence of
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valid biomarkers. Unpredictable results after stroke, particularly in those who do not follow the rule of
proportional recovery (Krakauer et  al.  2015), mean that  clinical  trials of  rehabilitation interventions
require hundreds of patients to be adequately fed. The use of biomarkers would allow to incorporate
accurate information on the underlying damage, and therefore the size of these intervention studies
could  be  greatly  reduced,  with  obvious  benefits  (Winters  et  al.  2016).  To  be  useful,  a  possible
biomarker must explain the recovery beyond what is indicated by the initial damage, i.e. more than is
currently achievable with the rule of proportional recovery. To fully understand the predictive capacity
of  biomarkers,  it  is  necessary  to  conduct  mechanistic  studies,  for  which  preclinical  models  are
fundamental. In addition, conducting longitudinal studies would provide useful data to better predict the
outcome or response of treatment. 
Functional  magnetic  resonance  imaging  (fMRI)  measures  brain  activity  by  detecting  changes
associated with blood flow. This technique is based on the fact that cerebral blood flow and neuronal
activation are coupled: when an area of the brain is in use, the blood flow to that region also increases.
This technique can also be used to study how the incidence of  stroke affects brain function. The
interaction between the affected cortex and its contralateral counterpart is a very interesting aspect in
the field. A very useful fMRI parameter to address this point is the index of laterality of the primary
motor cortex, i.e. how active the contralateral motor cortex is compared to the ipsilateral one during an
unilateral motor task. In the subacute stage, the stroke condition is associated with a less lateralized
activation than in healthy subjects, in particular an ipsilateral compensatory recruitment is observed
(Feydy et al. 2002). An emerging notion in the field is that the greater the involvement of the affected
motor network, the better the recovery. This hypothesis is supported by the increased activity of the
primary motor  cortex affected induced by motor  training and acute pharmacological  interventions,
parallel  to  the  improvement  of  motor  function  (Calautti  et  al.  2003).  Dong  and  colleagues  also
demonstrated that  the laterality  index was able  to predict  response to  constraint  induced therapy
(Dong et al. 2006). In addition to measuring the activity of precise brain areas during a particular task,
fMRI allows the study of functional connectivity between different regions, examining the consistency
of activation between them during rest. The results of functional connectivity of the resting state (rsFC)
in the early and late subacute phases converge on the conclusion that interhemispheric connectivity is
particularly important for motor control. Acute interruption of rsFC at the level of specific networks has
been shown to be related to higher initial deficits (Carter et al. 2010, Baldassarre et al. 2016) and
insufficient recovery at six months (Park et al. 2011). 
Magnetoencephalography (MEG) or electroencephalography (EEG), non-invasive measures of cortical
neuronal  oscillations,  are  sensitive  to  alterations  of  cerebral  blood  flow (Nagata  et  al.  1989).  In
addition, multichannel recordings can provide insights on functional connectivity of brain areas, also in
a spectral band-specific fashion. Several studies have focused on the correlation between spectral
bands alteration and initial deficit. For instance, Wu et al. employed a regression analysis of spectral
power  with  behavioural  impairment  scores (NIHSS),  and  established that  higher  delta  power  and
reduced beta activity correlate with more severe NIHSS scores. More crucially, this relationship of high
delta/low beta was prominent in electrode clusters overlying the ipsilesional sensorimotor cortex (Wu
et al.  2016).  
Apart from its usefulness for diagnosis, neurophysiological measurements have been shown to have
some predictive  power.  The loss of  power in  the alpha band and the increase in  the delta  band
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detected within 2 weeks of stroke are linked to an unfavourable outcome (Finnigan et al. 2013). In the
same study,  these indices were shown to provide unique, real-time information on the efficacy of
thrombolytic therapy prior to clinical changes, thus informing decisions on alternative interventions
(Finnigan et al. 2013). Consistently, Laaksonen and his collaborators found that patients with poorer
stroke outcomes had persistent and increased low-frequency oscillations in acute and early and late
subacute stages (Laaksonen et al. 2013), suggesting predominant inhibitory mechanisms in the peri-
lesional cortex. Pushed to extremes, the absence of delta activity and the presence of theta and fast
beta frequencies herald a benign course, here understood as patient survival (Burghaus et al. 2007).
As for fMRI studies, EEG allows to explore the connectivity between different brain area, looking at
functional  networks.  Nicolo  and  collaborators  recorded  resting  EEGs  within  3  weeks  of  stroke
symptom onset and coherence in the beta frequency band between the ipsilesional primary motor
cortex and the rest of the cortex was evaluated. A higher coherence was correlated with improvements
in a composite score of upper-limb motor performance during the first 3 months after stroke (Nicolo et
al.  2015).  In addition to resting state recording,  EEG/MEG measurements can be performed also
during the execution of a task. For instance, a movement-related desynchronization in the beta band
at the level of primary motor cortex is observed when a subject produces an unimanual movement.
When compared to control subjects, stroke patients exhibit a significantly reduced movement-related
beta desynchronization (MRBD). Interestingly, within the patient group, smaller MRBD was seen in
those with more motor impairment (Rossiter et al. 2014).  
The translation potential  of  the EEG biomarker for patients is high, as the EEG is already part of
standard clinical practice. However, further work is needed to develop automated data processing for
easier use by physicians and to identify other EEG biomarkers that can make individual predictions
rather than by patient groups. 
1.4.2 Measures of anatomical/structural injury
Several  structural  biomarkers  of  neuroimaging  have  been studied  in  patients  with  stroke.
These markers include quantitative characterization of the lesion of the stroke itself, as well as the
structure and function of unharmed brain areas.
Acute infarct volume can be measured with computerized tomography (CT) or magnetic resonance
imaging (MRI).  Infarct  size correlates with motor outcome, evaluated with the National Institute of
Health  Stroke  Severity  (NIHSS)  score.  However,  this  relationship  is  significantly  attenuated  with
increasing leukoaraiosis (i.e.  white  matter  disease) (Helenius et  al.  2015).  For  what concerns the
ischemic penumbra, recent data suggest that the site of ischemic penumbra, rather than volume, is the
most informative parameter. As a matter of fact, infarction of an extremely well localized area of the
periventricular white matter and the adjacent internal capsule is related to poor outcomes after MCA
stroke (Rosso et al. 2014). Even the constriction of the damaged area can be an informative index, in
fact,  shrinkage  of  brain  tissue  was  detected  in  all  patients  in  the  perilesional  cortical  structures
(Kraemer et al., 2004). This study suggests that brain atrophy after acute ischemic stroke involved
areas anatomically connected with the ischemic brain lesion but nevertheless was accompanied by a
simultaneous improvement of the neurological deficit.  
Another structure whose integrity is relevant for motor outcome is the corticospinal tract (CST). White
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matter bundles integrity can be studied by means of diffusion-weighted magnetic resonance imaging
(DW-MRI). This technique is based on the concept that water tends to diffuse more rapidly in the
direction aligned with the internal structure that contains it, e.g. bundles of axons, and more slowly as it
moves perpendicular to the preferred direction. Thus, it is possible to derive directional information of
white matter tracts brain-wide. Measurement of CST integrity in the acute phase via diffusion tensor
imaging (DTI,  a modality of  DW-MRI),  which reflects fibre number,  predicts motor recovery (Fugl-
Meyer score) at 12 months. Another method use as biomarker the CST lesion load, calculated by
overlaying  the  patient's  lesion  map  on  magnetic  resonance  imaging  with  a  probabilistic  CST
constructed from healthy control subjects (Feng et al. 2015). Several studies have found that even
when measured in the late subacute-chronic stage (> 4 months), the extent of CST injury also helps in
predicting subsequent treatment response. For instance, Nouri and collaborators showed that those
patients benefiting more from an epidural motor cortex stimulation had a smaller fraction of damaged
CST compared to those who did not (44% vs 72%), and rarely had severe tract injury (Nouri et al.
2011).
However, an approach that integrates characteristics extracted from multiple brain areas, rather than
only  in  the  injured  area,  can  better  predict  motor  outcome  and  recovery.  In  a  recent  study,  an
automatic learning method was used to differentiate severe patients with subsequent good or poor
recovery of the upper limb based exclusively on structural magnetic resonance imaging. The authors
demonstrated that, while considering only CST damage led to a classification accuracy of 73%, the
use  of  other  motor  areas  (not  the  corticospinal  tract)  provided  an  accuracy  of  87%,  and  the
combination  of  both  led  to  an  accuracy  of  90%.  This  proof  of  concept  approach  highlights  the
importance of  considering different  anatomical  structures in order  to better predict  motor recovery
(Rondina et al. 2017). 
1.4.3 Combined approaches
The  combination  of  neuroimaging  and  neurophysiological  biomarkers  can  be  useful  in
predicting motor  outcomes and response to therapy.  Limb outcomes above three months can be
predicted in the first subacute phase by first measuring clinical biomarkers, then MRI in a stepwise
approach, as established in the so-called PREP (Predicting Recovery Potential) algorithm (Stinear et
al.  2012).  As  for  the  response  to  therapy,  a  recent  study  pointed  out  that  the  combination  of
neuroimaging structural damage characteristics and functional measures of the saved networks (e.g.
EEG and fMRI) was the key to best predict the response to a standardized robotic therapy in the
chronic phase (Burke Quinlan et al. 2015). The trials for rsFC, fMRI and MEG/EEG biomarkers are
promising and represent a priority area of development. 
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1.5 Aims of the study
Stroke is a major cause of adult disability worldwide. Currently, there are no effective therapies
to  treat  this  condition  and  there  valid  methods  to  determine  the  extent  of  recovery  in  individual
subjects. There is therefore a great need for reliable biomarkers that predict spontaneous recovery
and new approaches to stimulate the recovery of lost functions. 
In this study I exploited a mouse model of stroke, the Middle Cerebral Artery Occlusion (MCAO), that
showed  a  high  variability  in  outcome  and  it  is  thus  close  to  the  human  condition.  I  conducted
experiments to evaluate the occurrence of motor deficits using different behavioural tasks: gridwalk
test,  skilled  reaching  test,  and  retraction  task  in  the M-platform (a  robotic  device  that  permits  to
quantitatively evaluate several kinetic/kinematic parameters related to forelimb movement). Moreover,
the ischemic lesion and electrophysiological  alterations were analysed by means of  histology and
electroencephalographic signals respectively. I studied how these parameters were altered by stroke.
Finally, I combined behavioural and anatomical data in order to define possible biomarkers that predict
long-term motor recovery.
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Chapter 2. Materials and Methods
2.1 Experimental design
All  procedures have been performed according to  the guidelines of  the Italian Ministry  of
Health for the care and maintenance of laboratory animals, and in strict compliance with EU Directive
No 2010/63/EU on the protection of animals used for scientific purposes. Animal testing at the Institute
of  Neuroscience  of  the  CNR  has  been  approved  by  the  Italian  Ministry  of  Health.  All  surgical
interventions were performed under deep anaesthesia and all efforts were made to minimize animal
suffering. To study the physiological changes that occur during MCAO induction, a total of 38 C57BL6J
mice (weighing 20-28g, age 8-12 weeks) were used. 
Firstly, animals were trained to learn the skilled reaching task for two weeks. Then, animals underwent
electrode implant and trained for an additional week in order to allow them to re-habituate to the
skilled reaching task after the surgery. During this re-habituation period animals were also shaped on
the robotic platform. At the end of the week the baseline performance in the skilled reaching, gridwalk
test  and  on  the  M-platform  was  acquired.  MCAO  was  induced  in  the  right  hemisphere.  Finally,
animals underwent behavioural testing in the gridwalk, skilled reaching test, M-platform at day 2 and
30 post MCAO. 
Moreover, to investigate possible post-stroke changes, the animals were recorded electrophysiological
both in freely-moving condition and during a retraction task on a robotic platform once every two
weeks (Figure 2.1). After 30 days, in order to perform anatomical analysis, animals were intracardially
perfused and immunohistochemistry assay was performed.
2.2 Electrode Implant
Animals were anesthetized with avertin (20ml/kg, 2,2,2 tribromoethanol 1.25%; Sigma-Aldrich,
USA), placed in a stereotaxic apparatus and the skull was exposed through a midline incision. Then,
two burr holes were drilled in both hemispheres at the level of Bregma (zero coordinate), 2mm lateral
(Figure. 2.2). 
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Figure2. 1: Timeline of experiments
 
This way, the electrodes were implanted in the caudal forelimb area (CFA) (Tennant et al 2001, Alia et
al. 2016). A surgical screw was tightened at the centre of the occipital bone and was used as ground
reference. Bipolar electrodes were assembled prior to the surgery:  a couple of  twitched insulated
tungsten wires (700μm spaced in length at the tip) were soldered at the channel and reference pins of
the connector (Elitalia).  After screw positioning, the electrodes were stereotactically inserted in the
centre of the drilled holes, at a depth in which the shorter wire was in contact with the dura mater, and
the ground pin was connected to the occipital screw. A first layer of dental cement (Optibond) was
distributed to secure all the components to the skull surface. After the first layer of cement was dried,
an aluminium post, used later to head-fix the animal, was cemented onto the skull. Finally, a second
layer of cement  (Paladur, Pala, Germany) was distributed to enclose all the electrical components.
After  the surgical  procedure,  animals  were treated with  paracetamol  (100mg/kg)  for  4  days  post-
operation in drinking water. 
2.3 Permanent Middle Cerebral Artery Occlusion
Animals  were  anaesthetized  with  avertin  (20ml/kg,  2,2,2  tribromoethanol  1.25%;  Sigma-
Aldrich, USA), transferred onto a heat blanket in lateral position and immobilised with adhesive tape
for medical use. A skin incision was performed between the ear and eye using surgical scissors. Then,
the temporal muscle was exposed, detached from the bone and cut vertically to show the underlying
skull. The MCA was identified and a craniotomy was drilled above it. Once it was exposed, the MCA
was  occluded  with  electrocoagulation  forceps  (biological  instruments,  bipolar  mode,  12W).  If
spontaneous  recanalization  occurred,  the  electrocoagulation  was  performed  again.  Finally,  the
temporal  muscle was relocated to its  position,  glued and the wound was sutured.  Sham animals
underwent the same procedure but without the electrocoagulation step. After the surgical procedure,
animals were treated with paracetamol (100mg/kg) for 4 days post-operation in drinking water. 
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Figure2. 2: Location of EEG electrodes.  E: 
electrode covering motor cortex
2.4 Immunohistochemistry
Brains were collected after transcardial perfusion of deeply anaesthetized mice with PBS (5
min) followed by 4% PFA. Brains were then post-fixed in 4% PFA for 2 hours and then kept in 30%
sucrose  in  Phosphate  Buffer  at  4°C.  Then,  they  were  sectioned  on  a  sliding  microtome  (Leica,
Germany)  into 50μm thick coronal sections, which were kept free-floating for further processing. Brain
slices were incubated in a blocking solution for 1 hour (10% horse serum; 0,3% Triton X-100 in PBS)
before applying the primary antibodies, dissolved at the proper concentration in 1% horse serum and
0.2% Triton X-100 in PBS. The following primary antibodies were used: guinea pig a-NeuN (1:1.000,
Millipore), rabbit  a-GFAP (1:500, Dako). After washing, slices were incubated with species-specific
secondary antibodies, dissolved in 1% horse serum and 0.2% Triton X-100 in PBS, for 2h at room
temperature. Nuclear staining was performed with (1:500) Hoechst (33342 Sigma). Coverslips were
mounted on glass slides with Vectashield. Images were acquired with epifluorescence microscope
equipped with Apotome (Zeiss).
2.5 Anatomical/structural measures
2.5.1 Lesion volume and CFA integrity
The volume and location of the lesion were assessed. In addition the enterity of the CFA, and
the shrinkage of the perilesional cortex were measured using an innovative overlapping-masks system
(Figure 2.3).
For anatomical analyses 1 out of every 6 sections was stained with NeuN and GFAP. The
lesion volume and the volume of the affected CFA for each animal were calculated by summing up all
damaged areas and multiplying the number by section thickness and by 6 (the spacing factor). To
avoid an underestimation of the lesioned volume due to the brain shrinkage that take place in the
ipsilesional cortex after the stroke, each damaged areas in each single brain slice was normalized by
its cortical shrinkage before summation (see below for the calculation of the cortical shrinkage) as
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Figure2. 3:  Measures considered after stroke
follow: 
To quantify the integrity of  the  CFA, we took advantage of previous findings on motor cortex
mapping. A red area, responsible for a forelimb movement in the 100% of tested animals  and a yellow area,
responsible for a forelimb movement in the 50% of tested animals were identified and superimposed on
each  coronal  section  mask  (Figure  2.4).  Then,  each  mask  was  overlapper  and  adapted  to  the
corresponding histological brain slice for the entire extension of the CFA, (from approximately -1,00mm
posterior up to +1,25 anterior to Bregma 0 suture). The adaptation of the masks to the histological brain
slices  was  accomplished  using  Photoshop  filters.  Subsequently,  using  a  digital  elaboration  software
(ImageJ),  the lesion  contour  was drawn,  thus  lesion area  and the percentage of  CFA affected  were
measured. 
The shrinkage of the tissue was measured firstly computing a volumetric factor (Vf), i.e. the
ratio between the healthy contralateral cortex and the corresponding section on the Paxinos atlas,
thus accounting for the real dimension of each brain.  Then, the atlas cortical area for each section has
been multiplied by the Vf to obtain the ideal cortical dimension of each section. Then the ipsilesional
cortical area was measured for each slice. Then we calculated the % of Cortical shrinkage (Cs) as the
difference  between the  theoretical  and  real  cortical  areas  normalized  on  the  theoretical  one  and
multiplied by 100 (Figure 2.5). Finally lesioned area for each section was divided by (1-Cs) and then
translated  in  a  volumetric  measure  by summing up all  corrected lesioned areas and multiplying the
number by section thickness and by 6 (the spacing factor).
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Figure2. 4: Lesioned CFA
2.5.2 White matter integrity
In order to test the hypothesis that loss in the descending motor pathways, measured at the level of
internal and external capsule, would determine motor deficit after a cortical stroke, the integrity of the white
matter was measured using a Luxol fast blue staining (Figure 2.6).
For each animal 2 50um-thick coronal brain slices located at 0mm, 0,5 mm and 1mm posterior to Bregma 0
were chosen. These slices were mounted on a gelatin-coated slide, then were rehydrated in distillate water
for 1 minute, ethanol 50%, ethanol 70%, ethanol 96% for 3 minutes each, so, slides were incubated at 60°C
with a Luxol fast blue solution overnight. Then slices were left to cool, after that they were placed in ethanol
96% 2 minutes for 2 times, ethanol 70% and ethanol 50%  for 3 minutes each. Distillate water 3 minutes for
2 times, lithium carbonate for 10 minutes, distillate water 3 minutes for 2 times, periodic acid for 8 minutes,
distillate water 3 minutes for 2 times and sulfur dioxide solution 1 minute for 3 times. Slices were rinsed in
running water for 15 minutes, than they were dehydrated in ethanol 50%, ethanol 70%, ethanol 96%,
ethanol 100% for 3 minutes each and xylene for 5 minutes. Slices were mounted with DPX. Successively,
slices were acquired using 20x magnification.  Finally we measured ipsilesional and contralesional
area of the internal and external capsula using the elaboration software ImageJ. 
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Figure2. 5: Example of shrinkage and  distortion. 
2.6 Behavioural tests
2.6.1 Reaching test
The animals  (food deprived  for  15h)  were  placed  in  a  testing  chamber  with  plastic  walls
(0.5x1.3cm) and trained to perform a skilled reaching test with their preferred paw, which had to pass
through a small frontal rectangular aperture to grasp and retrieve food pellets (Figure. 2.7 A). The task
was video recorded from the side of the tested forelimb. Each attempt was classified as follows: (i)
correct: the pellet was grasped and taken directly to the mouth; (ii) dropped: the pellet was grasped but
it fell right before entering the chamber or inside of it; (iii) displaced: the pellet was not grasped but just
displaced from its position; (iv) missed: the paw crossed the frontal window but the pellet was not
displaced. 
Then, the percentage for the single categories was calculated over the total attempts, a cumulative
score of the performance was calculated as follows:
2.6.2 Gridwalk test
Animals  were  allowed  to  freely  walk  for  5  minutes  on  an  elevated  grid  (32x20cm,  with
11x11mm large openings) and the task was video recorded (Figure. 2.7 B). The video recordings were
analysed off-line by means of a custom-designed Graphical User Interface implemented in Matlab, to
assess correct steps and foot-faults, i.e. steps not providing body support, with the foot falling into grid
hole. The percentage of foot faults for each limb was then calculated.
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Figure2. 6: White matter assessment. (A) Internal and Eternal capsule of -1,00 Bregma slices were labelled 
using Luxol fast blue staining. (B) Mouse brain atlas used as a reference.
2.6.3 Robot task
We measured forelimb performances in a robotic device, the M-Platform (Figure. 2.8), where
the animal had to pull back a handle in order to get a liquid reward (Spalletti et al., 2014, 2017) thereby
allowing the assessment of kinetic and kinematic parameters. 
The main components of the M-platform (Figure. 2.8 A), are a linear actuator (Micro Cylinder RCL,
IAI, Germany), a 6-axis load cell (Nano 17, ATI Industrial Automation, USA) and a custom designed
handle that was fastened to the wrist of the mouse and placed on a precision linear IKO slide (IKO
BWU 25-75, USA).
During experiments, the animal was kept in a U-shaped restrainer (interior dimensions 35×80×30mm)
and head-fixed on the platform by means of a post cemented to the skull. Its left wrist was blocked to
the slide through the handle.
The task was a pulling/retraction movement and included two phases: a passive phase and an active
phase. During the first phase the linear actuator pushed the slide, where the wrist of the animal was
blocked, to extend its forelimb in parallel to the sagittal plane. Then, the active phase started and the
motor was quickly decoupled from the slide and the animal could voluntarily pull back the slide to the
rest position. Animals were water-deprived for 15h and receive a milk droplet as a reward for each
complete retraction. 
Several robot parameters were evaluated: (i) the latency to the first retraction (i.e. the time elapsed
before the first force peak) (ii) the t-target, i.e., the time spent by the animal to accomplish a single
retraction task; (iii) the number of sub-movements needed to complete the task; (iv) the number of
attempts, i.e., the number of force-peaks not corresponding to a sub-movements (i.e. below the static
friction force) (Figure. 2.8 B). For each session, a number of 25-30 trials, i.e. full extension-retraction
cycles, were performed.
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Figure2. 7: Behavioral tests. (A) Reaching task. (B) Gridwalk test.
2.6.4 Motor score
In order to combine all behavioural informations, we implemented a global motor score, that
contain all behavioural tests in a single total score. For this, the scores of each behavioural tests are
converted  in  a  scale  from  0  to  10.  Score  0  was  assigned  to  animals  that  didn't  have  a  good
performance, while score 10 to  extremely high performing animals.
For each test the score was assigned as follow:
• Gridwalk test:
10%-60% errors → 10-0 score
< 10% errors  →  10  score
> 60% errors  →  0  score
• Reaching test:
The entire dynamic range was maintained.
• Robot task:
Latency  0-1000 → 10-0 score
>1000  → 0 score   
T-target 0-2500 → 10-0 score
>2500  → 0 score
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Figure2. 8: M-Platform. (A) Main components of the M-platform. (B) Parameters extracted from retraction 
movement. 
Attempts 0-5 → 10-0 score
>5  → 0 score
The same classification was applied for the isometric measures. 
Amplitude 0-0,8 → 0-10 score
>0,8  → 10 score
AUC 0-15 → 0-10 score
>15  → 10 score
2.6.5 Statistical Analysis
All statistical tests were performed using SigmaPlot 12.0 (Systat Software Inc, USA). For comparisons
between different groups, a Two-Way Repeated Measures ANOVA was used followed by Tukey Test.
In all graphs, data are reported as mean ± standard error. 
2.7 Neurophysiological recordings
2.7.1 Electrophysiology in freely moving
Spontaneous neuronal  activity in  both  controls  and ischemic animals was acquired during
freely  moving  behaviour  before  surgery  and  then  once  every  two  weeks,  starting  from  day  2.
Recordings  were  performed  in  a  test  cage  for  a  30min  session,  using  a  2channels  extracellular
amplifier (Npi electronic, Germany). Cortical local field potentials (LFP) were 10’000X amplified and
0.3–100Hz  band-passed.  We  focused  on  estimating  the  power  content  of  the  standard
neurophysiological spectral bands: delta = (0.5 − 4) Hz, theta = (4.1 − 8) Hz, alpha = (8.1 − 12) Hz,
beta = (12.1 −30) Hz, gamma = (30.1−50) Hz of the LFP signal.  
2.7.2 Electrophysiology onto the robotic platform
Recordings of local field potentials (LFPs) were performed from both hemispheres during the
retraction task in the M-Platform. Signals has been bandpass filtered (3 - 100Hz), amplified and fed to
recording system (Plexon). Recordings were carried out before and at 2 and 30 days after MCAO.
From these recordings, we estimate several physiological parameters, including the distribution of LFP
power  in  the  different  spectral  bands,  amplitude  and  latency  of  event-related  potentials  (ERPs)
triggered by force peaks measured in the M-Platform. 
Data  were  processed  with  the  software  NeuroExplorer  to  obtain  the  the  event-related  potentials
(ERPs) associated with the force peak generation. Neural signals were aligned on the onset of the
force peak and amplitude parameter were extracted by means of a Matlab custom-made GUI.
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Chapter 3. Results
3.1  Post-stroke anatomical alterations
3.1.1 Lesion volume and cortical integrity
Permanent Middle Cerebral Artery Occlusion (MCAO) is an experimental model close to the
human condition,  in which a significant  percentage of  strokes affects the territory of  the MCA. To
understand if this model could represent the human condition also in terms of variability of the lesion
volume, allowing us to investigate mechanisms that go beyond spontaneous motor recovery, we have
characterized anatomical changes that occur 30 days after the stroke. Thus, we assessed the lesion
volume in the targeted cortical areas and via immunohistochemistry for a neuronal and an astroglial
marker, i.e. NeuN and GFAP respectively  (Figure 3.1). At 30dpl, within the lesion, the NeuN signal
could still be detected, but its pattern was extremely different from that of the healthy cortex (Figure
3.1 A-C):  in  fact,  after  the lesion neurons appeared narrower  and less dense  (Figure 3.1  D,  E).
Intense astrogliosis was present in a large portion of the ipsilesional hemisphere, particularly along the
contour of the lesion (Figure 3.1 F). 
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Figure3. 1: Histological brain slices at 30dpl. (A) NeuN staining of histological brain slice at bregma level of
healthy cortex.  (B) Detail of the sane cortical thickness that show its typical pattern.  (C) GFAP staining of
histological brain slice of healthy cortex at bregma level. (D) NeuN immunoistochemistry of histological brai
slice 30 days after MCAO induction.  (E) Detail of the lesion.  (F) GFAP immunoistochemistry of histological
brain  slice  30  days  after  MCAO  induction.  (G)  Representation  of  lesion  extension  at  30dpl  along  the
anteroposterior axis (n=15). In the x axis Bregma level, in the y axis lesion volume.
Among the animals (n=15), the lesion had a volume of 4.00 ± 0.625 mm3, covered a region
between 2.4 mm anterior to Bregma 0 and 2.1 mm posterior to Bregma 0, and reached its maximum
area around the Bregma 0 suture  (Figure 3.1 G).  We found a considerable variability in terms of
localization of the lesion along the mediolateral axis. This high variability in the location of the lesion
can  be  easily  appreciated  by  comparing  the  same  cerebral  coronal  slice  of  different  animals
undergoing MCAO (Figure 3.2).
The distortion caused by shrinkage is an important parameter that could contribute to neural
impairment due to tissue compression, so it could be considered as a possible biomarker. On average,
the lesion reduced the ipsilesional cortical  area by 19.36 ± 2.25 %, and neural  tissue contraction
tended to be greater around Bregma 0 where the area of cortical damage is larger (Figure 3.3 A). As
expected, the percentage of ipsicortical shrinkage among animals strongly and positively correlates
with the extension of the lesion volume. In fact, after a stroke, the ischaemic area fills rapidly with scar
tissue, which, after the reduction of the initial oedema, tends to shrink, leading to the lengthening of the
perilesional tissues and an eventual worsening of the initial damage (Figure 3.3 B).
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Figure3. 2:  NeuN staining of at Bregma level 0 in six different MCAO animals 30dpl. The same mask was
superimposed on each slice to highlight Caudal Forelimb Area location.  
Figure3. 3: Ipsilesional cortical shrinkage at 30dpl. (A) Percentage of ipsilesional cortex shrinkage along the 
anteroposterior axis. In the x axis Bregma level, in the y axis percentage of shrinkage in the lesioned hemisphere. 
(B) Correlation among cortical shrinkage and lesion volume (linear regression R=0,713989) (n=15). In the x axis 
lesion volume, in the y axis percentage of shrinkage in the lesioned hemisphere.
The ischaemic lesion mainly interested the somatosensory areas, while motor areas, including
the  CFA,  were  only  partially  affected.   A damage  in  the  CFA should  directly  affect  the  motor
performance of the contralateral forelimb. However, previous studies highlight the great potential of
perilesional  tissues  to  partially  guide  the  recovery  of  lost  motor  function  through  neuroplastic
rearrangements of the surrounding motor cortex (Alia et al. 2016). Out of the 15 MCAO animals, only 5
showed significant ischemic damage in the CFA (percentage of injured CFA > 5%)  (Figure 3.4 A). The
same five animals also had the largest lesions, with the somatosensory area as the main target of the
MCAO, while the CFA resided in the perilesional site and was involved only with larger lesions. Among
these animals (n=5) 12.86% ± 1.95% of the CFA was injured, with greater posterior damage to the
Bregma 0 suture (Figure 3.4 B).
3.1.2 White matter integrity
Today, the most robust imaging biomarkers to predict motor recovery and outcome in humans
after stroke are measures of white matter integrity of the corticospinal tract (CST). To study this aspect
on the murine MCAO model, we directly measured the integrity of the white matter in the internal and
external capsule on histological slices of the brain obtained 30 days after the induction of the lesion.
The white matter was stained with Luxol fast blue and measurements were performed on slices of
0mm, 0,5mm and 1mm behind the Bregma 0 (see Materials and Methods) (Figure 3.5).
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Figure3. 4:  CFA lesion on 30dpl histological brain slice. (A) Percentage of lesioned CFA among MCAO mice 
(n=15). (B) Percentage of damaged CFA along anteroposterior axis in animals that reported a consistent (>5%) 
damage in CFA (n=5). In the x axis Bregma level 0, in the y axis percentage of CFA damaged.
Figure3. 5: Histological brain slice stained with Luxol fast blue protocol. Example of
sane brain coronal sections of 1mm behind the Bregma 0.
We found that the ratio between ipsilesional and contralesional quantities of white matter was
lower for the MCAO animal than for Sham, measuring both the external (n=17) and internal (n=8)
capsules. However, only the difference in the external capsule area was statistically relevant when
compared between sham and MCAO animals (p < 0.05). It is possible that the differences related to
the internal capsule were not statistically significant because of the lower number of animals analysed
(Figure 3.6).
3.2 Alterations in motor function after MCAO
In  order  to  evaluate  the deficit  at  the behavioural  level  we  exploited different  motor  tests
evaluating the general functionality or fine motor control. One of these test is the skilled reaching test,
which allows to evaluate finer motor performance, i.e. the grasping of a food pellet. After 2-3 weeks of
training, baseline performance was measured and then the test was repeated at 2dpl (acute phase)
and  30dpl  (chronic  phase).  During  the  scoring  procedure,  “correct”  movements  and  errors  were
evaluated.  In  addition,  errors  were  further  divided  into  “dropped”,  “displaced”  and  “missed”  (see
Materials and Methods). As expected, after the lesion, we observed a significantly decrease in the
number of “correct” movements at 2dpl in MCAO group (n=25), whereas the sham group did not show
significant differences (p<0.001)  (Figure 3.7 A). At the behavioural level, we observed that lesioned
animals started to generate “clumsy movements”, in which the animal is not able to grasp the pellet or
even to centre the frontal aperture and that were thus classified as “missed”. We reasoned that this
“missed” category represented the most severe type of error, given that in this case the animal is not
even able to reach or displace the pellet, in fact  percentage of errors, in particular missed movements
increased after stroke (Figure 3.7 B). The sham group did not show significant differences (n=13).
Given that motor performance in the skilled reaching test appeared quite variable even for the same
animal,  we  exploited  a  cumulative  score  in  which  a  fixed  value  is  attributed  to  each  class  of
movements: 1 for “correct”, 0.66 for “dropped”, 0.33 for “displaced” and 0 for “missed”. This scoring
method revealed to be more robust than just considering the number of “correct”.  We observed a
functional decrease at 2dpl with a spontaneous recovery at 30dpl (Figure 3.7 C).
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Figure3. 6:  Ipsi/Contra ratio of white matter integrity. (A) Ipsi/contra ratio integrity of the External Capsula. (B)
Ipsi/contra ratio integrity of the Internal Capsula. *’ represents significant difference from the baseline: *, p < 0.05. 
 An easy way to assess motor damage of all the four limbs is the gridwalk test. An animal is
placed on an elevated grid with opening (see Materials and Methods). Animals without brain damage
usually put their paws precisely on the wire frame to hold themselves while moving along the grid.
Each time a paw slips through an open grid, a "foot fault" is recorded. Sham animals generally show
few foot faults for both forelimbs. We evaluated the percentage of foot faults in both the affected (i.e.
contralateral to the lesion) and healthy (i.e. ipsilateral) forelimb. After the induction of MCAO, there was
a significant deficit in the use of the affected forelimb at 2dpl (p<0.001), which did not recover up to
30dpl.  We observed a significant  difference with  the sham group for  both  time points  considered
(p<0.001, MCAO=18, sham=13) (Figure 3.8).
Moreover,  we  used  a  robotic  platform  developed  in  our  lab,  the  M-platform,  to  add  a
quantitative measure of the motor deficit induced by the MCAO. This device provides a quantitative
assessment  of  anterior  limb flexion  movement,  is  sensitive  to  detect  performance deficits  after  a
localized cortical stroke, and measures functional improvements during post-stroke training (Spalletti
et al. 2014, Pasquini et al. 2018). Mice (n=29) were allowed to familiarize with the setup for a week
before measuring baseline performance and then, animals were tested again on the robotic platform at
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Figure3. 7:  Analysis of skilled reaching test performance. (A) Percentage of “correct” before and after 
MCAO induction. (B) Proportion of “missed” over the total number of “errors”. (C) Cumulative score. (*) 
represents significant difference from the baseline, ***, p < 0.001. ‘#’ represents significant difference from the 
sham group, ###, p < 0.001. (n=38; MCAO=25, sham=13). 
2 and 30 days after the injury. We analysed 4 different parameters: latency, t-target, submovements
and attempts (Figure 3.9) (see Materials and Methods).
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Figure3. 8: Analysis of gridwalk test performance. Percentage of foot faults. (*) represents significant difference
from the baseline, ***, p < 0.001. ‘#’ represents significant difference from the sham group, ###, p < 0.001 (n=31; 
MCAO= 18, sham=13).
Figure3. 9: Analysis of robot task performance. (A) Latency. (B) T-target. (C) Attempts. (D) Submovements. (*) 
represents significant difference from the baseline, ***, p < 0.001,**, p<0.01. ‘#’ represents significant difference from 
the sham group, ###, p < 0.001, ##, p<0.01 (n=29; MCAO=16, sham=13).
We observed that the difference between 2dpl and baseline performance was significantly higher in
MCAO animals than in sham for latency, t-target and attempts. Indeed, the MCAO group took longer to
start performing the task (Figure 3.9 A), spent more time to accomplish the retraction task (Figure 3.9
B) and  made  more  attempts  (abortive  tries  not  resulting  in  a  movements)  at  2dpl  showing  an
improvement trend at 30dpl (Figure 3.9 C).We did not found statistically difference in the number of
submovements.(Figure 3.9 D). We also observed a progressive improvement in the performance of
the sham group, probably due to learning. 
The M-platform allows also to perform an isometric task (45s of duration), in which the forelimb
is kept extended and the amplitude of the exerted force and its relative area-under-the-curve (AUC) of
each peak was measured with the idea of evaluating the maximum force of the animal (Figure 3.10).
Even in this case, sham animals (n=12) tended to improve their performance in terms of force peak
amplitude, reaching the statistical significance at 2dpl. By contrast MCAO group (n=16) reduced its
performance soon after the lesion and continue to reduce its force peak at 30dpl  (Figure 3.10 A).
Coherently, the AUC parameter significantly decreased 2 days post-stroke and remained significantly
affected up to 30dpl (Figure 3.10 B).
 
To combine all behavioural results a novel motor score was established  including all motor
tests  together  for  the  different  time-points  considered.  For  this,  performance  relative  to  each
behavioural tests was converted in a range from 0 to 10 (see Materials and Methods). The differences
between sham (n=12) and MCAO groups (n=22) were showed as a radar plot, where each test is
represented on one axis. We observed a retraction of the plotted orange area in MCAO group due to
loss of motor function, while the green plot relative to sham group remained almost unchanged over
time (Figure 3.11). 
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Figure3. 10:  Analysis of isometric performance. (A) Amplitude. (B) AUC. (*) represents significant difference 
from the baseline, ***, p < 0.001,**, p<0.01 (n=29; MCAO=16, sham=12).
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Figure3. 11: Motor score. MCAO and sham motor score for all time-points considerate (n=34; MCAO=22, sham=12). 
Then, we have calculated the total score as a sum of total of converted points, mimicking what
is done with clinical  scales for humans. We quantified a significant  decrease of  the overall  motor
function in the MCAO animals at 2dpl with a  trend of improvement observed at 30dpl (Figure 3.12).
To the contrary, sham animals showed no longitudinal differences in the overall motor performance.
3.3 Proportional recovery in MCAO model 
Since our starting goal was to establish a stroke model characterized by a large variability in
order to mimic the human stroke condition, where a proportional recovery rules has been observed,
we evaluated if animals in our MCAO groups (n=13) followed a proportional recovery as well as in
humans. Firstly we considered the global motor score including the performance of all used motor
tests. We found that after normalizing performance on the baseline values, the acute motor function
(assessed at 2 days after stroke) was greatly variable among animals showing a range of motor deficit
going  from  a  really  mild  (acute  performance  close  to  100%)  to  a  really  severe  (close  to  0%)
impairment. Moreover, we found that some mice increased their global motor performance at 30 days
post  lesion  (Figure 3.13 light red) while other mice not  recovered or even worsened their  motor
function in the chronic phase (Figure 3.13 red).
Thus it  is  possible to subdivide our ischemic animals in good or poor recovers strengthening the
similarity with human stroke patients.
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Figure3. 13: Recovery trend in MCAO group. In the y axis % of pre-stroke performance. In the x axis recovery 
after stroke for each animal (n=13).
Figure3. 12: Motor score sum.(*) represents significant difference from the baseline, ***, p < 0.001,*, p < 0.05. 
‘#’ represents significant difference from the sham group, ###, p < 0.001 (n=34; MCAO=22, sham=12).
Given that it has been suggested that the acute deficit could be a strong predictor of chronic
motor  improvement  in  humans,  we  assessed  whether  a  correlation  among  acute  and  chronic
performance was evident  in  our  data  (n=13).  We obtained  acute  performance by subtracting the
baseline  from performance at  day  2,  while  chronic  performance was obtained  by  subtracting  the
baseline from day 30 its baseline. Interestingly, we found a positive correlation between the acute and
the chronic global  motor performance,  making the early deficit  as a good predictor  of  final  motor
outcome as well as in humans (Figure 3.14).
3.4 Preliminary correlation between functional and anatomical changes
We were also interested in evaluating if anatomical parameters could predict motor outcome in
the acute and chronic phases. Thus, we performed simple linear regressions among the performance
of the animals analysed in different  behavioural  tasks and each anatomical  change we quantified
(n=15). We found a good trend between the score obtained in the reaching test and the volume of the
lesion (Figure 3.15).
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Figure3. 15: Linear regression between reaching test and lesion volume. Regression between acute or late 
performance in reaching task and lesion volume in mice underwent MCAO. (n=15).
Figure3. 14: Acute deficit trend in MCAO group (n=13). In the x axis initial deficit of 
acute phase, in the y axis final deficit in chronic phase.
The data also seems to correlated in  only the animals with the injured CFA were considered (n=5).
Instead, no robust correlations have been found in animals with intact CFA (Figure 3.16).
Among animals with CFA damage we also found that the acute (but not chronic performance)
in the isometric task has a tendency both with the % of lesioned CFA (Figure 3.17 A) and with the
volume  of  the  lesion  (Figure  3.17  B),  confirming  that  anatomical  parameters  could  be  good
biomarkers of post-stroke motor function.
3.5 Electrophysiological alterations after MCAO
3.5.1 MCAO-induced power spectral density changes
Since  MCAO  spares  most  of  the  area  of  the  CFA,  the  MCAO  model  allows  to  study
electrophysiological alterations in this region and to link them to the behavioural outcome. So, in order
to identify possible predictors of functional outcome after stroke, we started to consider if induction of
MCAO produced  measurable  electrophysiological  changes.  For  this  purpose,  we  recorded  neural
signals from animals in freely moving condition by means of chronic electrodes implanted bilaterally in
the CFA. The recordings were made longitudinally before the induction of the stroke and then at 2, 16
and  30dpl,  analysing  power  spectral  density  in  standard  electrophysiological  bands  (delta,  theta,
alpha, beta and gamma, see Materials and Methods).
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Figure3. 16:  Linear regression between reaching test and CFA lesioned mice. Regression between acute or
late performance in reaching task and lesion volume or the percentage of lesioned CFA in MCAO mice that 
repeated a robust damage on the CFA (n=5).
Figure3.  17:  Linear  regression  between  isometric  task  and  CFA,  volume  lesioned  mice.  Regression
between isometric task acute performance and lesion volume or percentage of lesioned CFA in MCAO mice that
showed a robust damage on the CFA (n=5). 
In the MCAO group we observed a significant decrease in the ipsi/contra ratio of the beta
power at 16dpl that further decreased at 30dpl, while for the sham group we did not observe changes
for any of the spectral bands (Figure 3.18).
In  particular,  looking  at  changes  occurring  in  the  single  ipsilateral  and  contralateral
hemispheres of MCAO animals (Figure 3.19), we found a progressive decrease in the power of the
theta, beta and gamma bands in the affected hemisphere. In addition, we noticed an increase in the
delta spectrum, which reached a statistical significance at 2dpl. 
For the healthy hemisphere, we observed significant changes at 2dpl for the gamma band but also, a
total reestablishment in the following days.
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Figure3. 18: EEG power spectral density changes after MCAO induction. Time course of power spectral 
density for standard electrophysiological bands. ‘*’ represents significant difference from the baseline, **, p < 0.01,
*, p < 0.05 (n=29; MCAO=16, sham=13).
     
Figure3. 19: EEG power spectral density changes in MCAO group. Time course of power spectral density for 
standard electrophysiological bands in the affected and healthy hemisphere, respectively. ‘*’ represents significant
difference from the baseline, ***, p < 0.001, **, p < 0.01, *, p < 0.05 (n=16).
3.5.2 Preliminary evaluation of electrophysiological changes in the M-platform
Recordings of local field potentials (LFPs) were also performed from both hemispheres during
the retraction  task  in  the M-Platform.  Since we wanted  to  better  characterize  electrophysiological
events that were associated with the generation of a force peak onto the M-platform, in order to study
them in the context of MCAO, we measured the amplitude of event-related potentials (ERPs obtained
by aligning neural signals on the start of each force peaks measured in the M-Platform) (Figure 3.20).
In  naïve  conditions,  a  well-defined  ERP is  easily  detectable,  showing  an  early  positive  and  late
negative phases. Stroke had a deleterious impact on the ERP shape, abolishing both the early and
late components at 2dpl (red trace) (Figure 3.20 A) The quantification of the peak-to-paek amplitude
confirmed a significant decrease at 2 days after stroke with a partial recovery of the ERP amplitude 16
and 30 days following the injury (Figure 3.20 B).
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Figure3. 20: Post-stroke evolution of electrophysiological parameters. (A) Representative traces of the Event
Related Potentials (ERP) aligned on the onset of the force peak. (B) Longitudinal variation of ERP amplitude in the
ipsilesional hemisphere at different times after stroke (n=8).
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Chapter 4. Discussion 
4.1 Anatomical and behavioural changes in MCAO induction
Stroke  is  a  highly  variable  condition  in  stroke  patients  and  functional  outcomes  strongly
depends of many factors. In this context, the MCAO is  a suitable model because it is similar to the
human condition. In fact, we have found that the lesion varied significantly in terms of extension and
localization (Figure 3.2). We also demonstrated that the focal site of the lesion involved predominantly
somatosensory areas, whereas the motor areas, including the CFA, were only partially affected or
represented a perilesional site. Indeed, only a minority of animals showed a robust damage in the CFA
(Figure 3.4).  As expected, the impairment of  the CFA was associated with larger lesions. MCAO-
induced lesion also provoked an imbalance in  the integrity of  the white  matter,  especially  for  the
external capsule. Anatomical alterations reflects in a loss of the contralateral forelimb motor function.
In fact, permanent MCAO determines a clear motor deficit at the level of the contralesional forelimb, as
we could observe in the gridwalk test (Figure 3.8). 
However, forelimb motor deficit extends beyond what can be assessed by means of gridwalk test, in
fact we could measure an impairment in the performance, during fine grasping behavior by means of
the  skilled  reaching  test.  Fine  grasping  behaviour  spontaneously  recovered  in  the  chronic  phase
(Figure 3.7).  This is in keeping with the idea that a damage of somatosensory areas may deprive
motor cortex of important inputs for motor adaptation and coordination (Mathis et al. 2017), but that
subsequent plastic phenomena can improve the overall function probably via recruiting compensatory
strategies.
We also utilized the M-platform (Figure 2.8)  to characterise the motor deficit associated with MCAO
(Spalletti et al. 2014). In this case, the M-platform was not used for rehabilitation, instead, we exploited
this tool for its ability to extract kinetic and kinematic parameters of the retraction movement. Also, the
M-platform allows to perform an isometric task, which provides additional parameters associated with
the  maximal  force  the  animals  is  able  to  generate.  Kinetic  and  kinematic  features  of  the  motor
performance during robotic tasks, showed a large panel of motor outcome in the late phase, with a
complete,  mild or without  any degree of  recovery (Figure 3.9,  3.10).Together with a deficit  in  the
performance of MCAO group on the robotic platform we observed an increase in the performance of
sham animals probably due to learning (Figure 3.9). 
Mimicking clinical scale for humans, in this thesis we also implemented a novel global motor score
(Figure 3.11)   accounting for all  the motor performance evaluated in the single motor tests.  This
general  motor  score showed a significant  drop in  the overall  motor  performance of  MCAO mice,
respect  both  baseline condition and sham animals (Figure 3.12).  Consistently  with  the functional
improvement observed in  the skilled reaching test  and in some kinetic  parameters relative  to  the
robotic task,  MCAO mice showed an significative increment in their  performance at 30 days post
lesion.
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4.2 Proportional recovery and preliminary correlation analysis 
The  proportional  recovery  rule  has  been  confirmed  in  the  motor  domain  several  times.
Evidence also suggests that  proportional  recovery applies to  non-motor  areas,  such as language
(Lazar et  al.  2010) and hemispatial  neglect  (Nijboer  et  al.  2013).  Moreover,  these recent findings
suggest that studies exploring the effect of any post-stroke therapy need to be contextualized in a
proportional  recovery  framework.  This  striking  clinical  phenomenon  provides  a  framework  for
investigating potentially modifiable biological factors that are necessary for maximizing recovery of
function and raises several clinical questions: (i) can we help patients with stroke to regain more than
70% of lost function and how, (ii) can we predict the long-term motor outcome, regardless the initial
impairment, (iii)  can we predict  if  a patient will  respond to a treatment, in order to customize the
therapy and (iv) how can we turn poor recovers into proportional recovers?  
In  this  project,  we  laid  the  bases  to  investigate  biomarkers  that  can  help  predicting  whether
proportional recover will occur or not.
For  this  we  needed  a  preclinical  model  characterized  by  such  variability.  The  MCAO  procedure
produces a large ischaemic lesion, the size of which is consistent with what is reported in the literature
(e.g. Llovera et al. 2014), but varies significantly in terms of extension and localization. In addition, the
lesion edges are difficult to identify due to a gradual decline in neuronal density from the ischemic
nucleus to the healthy tissue, which is consistent with the established presence of a penumbra in this
model (Carmichael et al.  2005). Both these aspects make the MCAO model similar to the human
condition. 
Thus, we verify if MCAO mice showed different inter-individual degree of recovery. Interestingly, we
found a segregation of poor and good recovers (Figure 3.13), meaning that some animals recovered
while others maintained their deficits.
Making advantage of this observed variability, we conducted a preliminary linear regression analysis
between anatomical measures and indices of motor recovery in our set of behavioural tests. First of all
we confirmed, as previously reported in the literature, that the extent of the acute deficit is a good
predictor for the late motor performance (Figure 3.14). The second aspect emerging from our data is
that  the also the lesion extension,  and particularly the eventual involvement of  the CFA, can give
valuable prediction of motor performance both in the skilled reaching test and in the isometric task
(Figure 3.15, 3.16, 3.17).
In the future, we will perform more sophisticated statistical analyses to assess the predictive power of
our parameters. 
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4.3 Post-stroke electrophysiological alterations 
In parallel with behavioural tests, we performed also electrophysiological measures both in
freely moving condition and during the retraction task onto the M-platform. For  the freely moving
condition,  we performed a standard analysis  of  the relative  power  of  electrophysiological  spectral
bands. We observed affected hemisphere-specific alterations in the power spectrum, in particular a
decrease in the beta, theta and gamma bands and an increase in the delta band (Figure 3.19). It has
been frequently reported,  both  in  humans and in  rodents,  that  an increase in  slow waves and a
decrease in rapid waves take place after stroke, i.e. increment of delta band and decline of beta bands
observed in our experiments.
We characterised also the event-related potential (ERP) associated with forelimb retraction  (Figure
3.17). Even in this case, we observed clear alterations after stroke. In particular, the reduced amplitude
of  the  peaks  could  be  associated  with  a  damaging  of  feed-forward  connections  from  the
somatosensory cortex (Petrof et al. 2015). Currently, we are analysing inter-hemispheric interactions,
which can be easily implemented given our set up of bilateral electrode recordings. Particularly, we are
using  different  quantitative  methods  of  time  series  analysis,  e.g.  cross-correlation  and  mutual
information.  Moreover, once completed,  we will  use our panel of  electrophysiological measures to
conduct  multiple  regression  together  with  anatomical  predictors,  in  order  to  delineate  a  possible
combination of anatomo-physiological factors useful to early predict the late motor recovery.
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